Category: Scientific Outputs
July 2018- Although highly effective, high-intensity cytotoxic treatments for Burkitt lymphoma are available in resource-rich settings, these therapies are usually not feasible in SSA, and lower-intensity continuous infusion approaches are impractical. We review current treatment approaches in SSA and discuss options for risk stratification and individualize therapy.
June 2018 – We discuss our experience in relation to others’ major contributions to paediatric Burkitt lymphoma care in sub-Saharan Africa. We believe that sharing of heterogeneous regional experience is valuable for rigorous examination, and look forward to on-going collaborative efforts to define best approaches for this disease, which we are actively pursuing with many … Continued